Aster DM Healthcare
604.90
+12.15(+2.05%)
Market Cap₹31,341.14 Cr
PE Ratio82.68
Company Performance:
1D+2.05%
1M+1.48%
6M+23.06%
1Y+74.30%
5Y+357.56%
View Company Insightsright
More news about Aster DM Healthcare
28Jul 25
Aster DM Healthcare Establishes New Subsidiary for Super-Specialty Hospital in Bengaluru
Aster DM Healthcare has incorporated a new wholly owned subsidiary, Aster DM Super-Specialty Hospital (Yeswanthpur) Private Limited, in Bengaluru, Karnataka. The subsidiary, formed on July 28, 2025, aims to set up and operate a super-specialty hospital. It has an authorized and paid-up share capital of Rs. 1,00,000, consisting of 10,000 equity shares of Rs. 10 each. Aster DM Healthcare holds 100% shareholding in the new entity, with an initial investment of Rs. 1,00,000 through cash subscription.
21May 25
Aster DM Healthcare: Q4 Profit Surge, GCC Business Separation, and Dividend Announcement
Aster DM Healthcare posted a consolidated net profit of ₹85.54 crore in Q4, reversing previous year's loss. Consolidated revenue grew 12% YoY to ₹4,138.46 crore. The company completed the separation of its GCC business, resulting in a gain of ₹5,148.09 crore. A final dividend of ₹1.00 per equity share was recommended.
20May 25
Aster DM Healthcare Reports Strong Q4 Results with Profit Turnaround and 20% EBITDA Growth
Aster DM Healthcare announced impressive Q4 financial results with significant improvements across key metrics. Revenue increased by 2.7% to ₹1,000.00 crore, EBITDA rose by 20.3% to ₹191.70 crore, and EBITDA margin expanded to 19.20%. The company turned profitable with a net profit of ₹79.00 crore, compared to a loss in the previous year. The board recommended a final dividend of ₹1.00 per equity share.
14May 25
Aster DM Healthcare to Unveil Q4 Financial Results on May 20
Aster DM Healthcare has announced it will consider its fourth quarter financial results on May 20, 2023. This board meeting will provide crucial insights into the company's financial performance for the most recent fiscal quarter. The results are expected to include key metrics such as revenue, profit margins, and earnings per share, offering a comprehensive view of the company's financial health and operational efficiency.
07May 25
Aster DM Healthcare Expands Footprint with 30-Year Hospital Lease in Bengaluru
Aster DM Healthcare has entered a 30-year lease agreement for a 430-bed multi-specialty hospital on Sarjapur Road, Bengaluru. This strategic move aims to expand the company's presence in India's tech hub, demonstrating long-term commitment to the region. The new facility is expected to improve healthcare access, generate employment, and potentially intensify competition in the local healthcare market.
30Apr 25
Aster DM Healthcare Acquires 5% Stake in Quality Care India for Rs 849 Crore Through Share Swap
Aster DM Healthcare has acquired a 5% stake in Quality Care India Limited (QCIL) through a share swap valued at ₹849.13 crore. This acquisition is the first step towards a planned merger between the two companies, announced in November 2023. The transaction involved Aster acquiring 1,90,46,028 QCIL shares from private equity investors in exchange for 1,86,07,969 of its own shares. The merger, expected to complete within the year, will create 'Aster DM Quality Care', jointly controlled by Aster Promoters and BCP.
19Apr 25
CCI Greenlights Merger of Aster DM Healthcare and Quality Care India, Creating Healthcare Powerhouse
The Competition Commission of India has approved the merger between Aster DM Healthcare and Quality Care India Ltd. The merged entity will become one of India's top three hospital chains with 38 hospitals and over 10,150 beds. This consolidation is expected to enhance healthcare access, achieve economies of scale, and strengthen competitive positioning in the Indian healthcare sector.
16Apr 25
Aster DM Healthcare's Proposed Transaction Receives CCI Approval
The Competition Commission of India (CCI) has granted approval for Aster DM Healthcare's proposed transaction involving BCP Asia, Centella, and Quality Care India Limited. This regulatory clearance marks a significant step forward in the deal, which could have substantial implications for the Indian healthcare sector. While specific details remain undisclosed, the approval may lead to strategic partnerships or changes that could reshape market dynamics and potentially improve healthcare services.
15Apr 25
Aster DM Healthcare's Proposed Transaction Receives CCI Approval
Aster DM Healthcare's proposed transaction involving BCP Asia, Centella, and Quality Care India Limited has received approval from the Competition Commission of India (CCI). This regulatory clearance is a significant milestone in the process, indicating that the deal does not raise major competition concerns in the Indian healthcare market. While specific details remain undisclosed, the transaction could potentially involve a merger, acquisition, or restructuring among the entities, potentially reshaping the healthcare landscape in their operational regions.
09Apr 25
Aster DM Healthcare Sees Significant Block Trade on NSE
A significant block trade of 524,994 shares of Aster DM Healthcare Ltd. occurred on the National Stock Exchange (NSE) at Rs. 479.40 per share, totaling Rs. 25.17 crores. This large-scale transaction in the healthcare company's stock has drawn market attention, potentially indicating shifts in institutional holdings or strategic moves by major shareholders.
28Mar 25
Aster DM Healthcare Sees Large Block Trade Amidst Strategic Financial Moves
Aster DM Healthcare witnessed a significant block trade on NSE, with 1,776,151 shares traded at Rs. 455.75 per share, totaling Rs. 80.95 crores. The company also executed a Loan Settlement and Call Payment Agreement with its associate, Alfaone Medicals Private Limited (AMPL), involving a Rs. 23.78 crore loan settlement and Rs. 47.56 crore fresh capital infusion. Aster currently holds 48.91% equity shares and 100% OCRPS in AMPL. The company announced a trading window closure from April 1, 2025, until 48 hours after FY2025 results announcement.
15Mar 25
Aster DM Healthcare: Ambitious Growth Plans Amid Management Changes
Aster DM Healthcare aims to double revenue to Rs 13,500 crore by FY2030, targeting a 20-25% CAGR. The company plans to expand key departments and merge with Quality Care India Ltd. Promoters have reduced share pledge from 99% to 41% through debt refinancing. Mr. Srinath Metla, Country Head – Sales & Marketing, has resigned effective June 13, 2025, with a 90-day notice period.
13Mar 25
Aster DM Healthcare Secures Approval for Preferential Share Issue in Non-Cash Deal
Aster DM Healthcare has received approval to issue 1.86 crore shares to non-promoters at a minimum price of ₹456.33 per share. The non-cash share swap arrangement has gained in-principle approval from NSE and BSE, pending CCI approval. The company must meet several conditions for final approval, including strengthening internal controls for monitoring trades by proposed allottees.
13Mar 25
Aster DM Healthcare Projects Strong Growth and Margin Expansion
Aster DM Healthcare has announced plans for significant growth and profitability. The company expects merger benefits to materialize in early FY26 and projects margins to reach 25% within 3-5 years. Management expressed confidence in growth plans, and promoters affirmed long-term commitment with no intention to sell their stake.
13Mar 25
Aster DM Healthcare Promoters Slash Pledged Shareholding from 99% to 41%
Aster DM Healthcare's promoters have significantly reduced their pledged shareholding from 99% to 41%. This substantial decrease suggests improved financial health for the promoters and could lead to increased investor confidence. The move may result in greater stock stability and provide the promoters with more strategic flexibility in decision-making for the company.
12Mar 25
Aster DM Healthcare Promoters Slash Share Pledge to 41% Following Debt Refinancing
Aster DM Healthcare has significantly reduced its promoters' share pledge from 99% to 41% following a strategic debt refinancing transaction with JP Morgan, HSBC, and Barclays. This move has resulted in improved loan terms, better loan-to-value ratios, and increased financial flexibility for the company. The reduction in share pledge suggests increased promoter confidence and may lead to positive market sentiment.
24Feb 25
Aster DM Healthcare Unveils ₹850 Crore Investment Plan for Kerala
Aster DM Healthcare plans to invest ₹850 crore in Kerala over the next three years, creating more than 4,200 new job opportunities. The investment is expected to expand healthcare facilities, establish new centers, upgrade medical technology, and enhance professional training. This move aims to boost local employment, improve healthcare services, and contribute to Kerala's economic development.
21Feb 25
Aster DM Healthcare Unveils ₹850 Crore Investment Plan for Kerala, Set to Create 4,200+ Jobs
Aster DM Healthcare has announced a ₹850 crore investment plan for Kerala over the next three years. This investment aims to expand healthcare infrastructure and is expected to create more than 4,200 new jobs. The move demonstrates the company's commitment to enhancing healthcare services and contributing to the state's economic growth.
Aster DM Healthcare
604.90
+12.15
(+2.05%)
1 Year Returns:+74.30%
Industry Peers
Max Healthcare Institute
1,246.00
(-1.47%)
Apollo Hospitals
7,498.00
(+0.64%)
Fortis Healthcare
857.45
(+1.75%)
Narayana Hrudayalaya
1,915.20
(-1.17%)
Global Health
1,311.20
(+0.38%)
Aster DM Healthcare
604.90
(+2.05%)